Lorraine Portelance, MD, is an internationally recognized pioneer in groundbreaking radiation modalities, and she is helping to usher in a new era of cancer treatment with proton therapy at Moffitt.

The Future of Radiation Is on Her Mind, But the Patients Are in Her Heart

Radiation oncologist Lorraine Portelance, MD, sees proton therapy as an ‘ideal weapon’ for targeting cancer

Can Triplet Therapy Help Treat Symptomatic Melanoma Brain Metastases?

Targeted therapy combined with immunotherapy gave patients longer progression-free survival and higher response rates, study says

Anna Phelan lying in a hospital bed, smiling at the camera

Young TikTok Star Shares Glioblastoma Journey

Anna Grace Phelan died from the rare and aggressive brain cancer at 19

A researcher puts liquid on a petri dish.

New Hope on the Horizon for Fighting Leptomeningeal Disease

Targeting branched-chain keto acids with phenylbutyrate could lead to better outcomes for those with leptomeningeal disease

Moffitt Treats First Glioblastoma Patient in Florida Using New Technology

Carthera’s Sonocloud-9 could eliminate challenges presented by the blood-brain barrier

Finding Strength in the Unexpected Challenges of Caregiving

Cassie Wood embraced support and empathy after her husband's brain cancer diagnosis.

UFC Fighters Inspire Young Moffitt Patients Facing Cancer

They bond over similarities in their approach to life

graphic image of a brain with a tumor and cancer cells

New Treatment Combines Electric Fields and Immunotherapy to Improve Survival for Glioblastoma Patients

Study shows promising results for patients with inoperable tumors, offering hope for better outcomes in one of the most aggressive forms of brain cancer

How Has President Jimmy Carter Survived Brain Cancer for 9 Years?

Moffitt experts explain how immunotherapy treatment is increasing survival for melanoma brain metastases

Endeavor

Cambiar el idioma